Lung and breast cancers are 12.3% of the 18 million cases diagnosed in 2018, with more than 2 million cases, respectively. Whiles, Colorectal cancer is in third place with almost 2 million new cases diagnosed in 2018.
Doctors diagnose cancersin several ways. The most common methods include laboratory tests (blood, urine, and others), biopsy,endoscopy, genetic tests, and imaging tests, such as X-ray,MRI, andultrasound.
Cancer data are alarming, and it is imperative to find new methods to detect cancer in the early stages.
Developing a ‘universal’ blood test
In the past years, researchers at the University of Bradford in the United Kingdom, have focused on a new “universal” blood test for earlier diagnosis of cancer.
They believe that this new test could help detect cancer in people who doctors think may have the disease. The research team partnered with a tech company to bring this revolutionary blood test to market.
This test is different from other universal cancer tests being developed because it is not looking for a specific biomarker or mutation. This is a generic test for cancer in an individual, regardless of the underlying mechanism that’s causing their cancer.”